| http://dbpedia.org/ontology/abstract
|
Chiron Corporation (/ˈkaɪrɒn/ KY-ron) was … Chiron Corporation (/ˈkaɪrɒn/ KY-ron) was an American multinational biotechnology firm founded in 1981, based in Emeryville, California, that was acquired by Novartis on April 20, 2006. It had offices and facilities in eighteen countries on five continents. Chiron's business and research was in three main areas: biopharmaceuticals, vaccines, and blood testing. Chiron's vaccines and blood testing units were combined to form Novartis Vaccines and Diagnostics, while Chiron BioPharmaceuticals was integrated into Novartis Pharmaceuticals. In 2014, Novartis completed the sale of its blood transfusion diagnostics unit to Grifols and announced agreements for the sale of its vaccines unit to GlaxoSmithKline.e of its vaccines unit to GlaxoSmithKline.
, Die Chiron Corporation war ein internation … Die Chiron Corporation war ein international aufgestelltes US-amerikanisches Biotechnologieunternehmen mit Sitz in Emeryville in Kalifornien, das am 20. April 2006 von Novartis übernommen wurde. Die Chiron Corporation wurde 1981 durch William Rutter, und gegründet und 1983 an die Börse gebracht. Den ersten Gewinn konnte das Unternehmen 1990 vorweisen. Im Jahr 1991 wurde die für 660 Millionen US-Dollar übernommen. Dies stellte die bis dahin größte Akquisition eines Biotechnologieunternehmens dar. Die Cetus Corp. hatte Aldesleukin (Interleukin-2, Proleukin®) entwickelt, das 1992 von der Food and Drug Administration (FDA) die Marktzulassung für die Behandlung von metastasierendem Nierenkrebs, und 1998 zur Behandlung des metastasierenden Melanoms bekam. Chiron erwarb 1995 die Iolab-Division von Johnson & Johnson sowie die aus San Diego, 1996 die Impfsparte der Behringwerke. Im Jahr 1997 verkaufte Chiron sein Geschäft mit Ophthalmika an Bausch & Lomb, 1998 die Division Chiron Diagnostics an die Bayer AG. Im Jahr 1994 kam es zur Zusammenarbeit der schweizerischen Ciba-Geigy, die 49,9 Prozent der Aktien übernahm. Mit dem Zusammenschluss von Ciba und Sandoz zu Novartis 1996 sank deren Anteil an der Chiron Corporation auf 44 Prozent. Ende 2005 kündigte Novartis an, Chiron für 48 US-Dollar pro Aktie zu übernehmen. Insgesamt kostete die Übernahme 5,1 Milliarden Dollar.stete die Übernahme 5,1 Milliarden Dollar.
|
| http://dbpedia.org/ontology/dissolutionDate
|
"2006-04-20"^^xsd:date
|
| http://dbpedia.org/ontology/fate
|
Acquired byNovartisin 2006.
, In 2014, its assets related to blood testing and vaccines subsequently sold toGrifolsandGlaxoSmithKline, respectively.
|
| http://dbpedia.org/ontology/foundingYear
|
1981
|
| http://dbpedia.org/ontology/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/ontology/location
|
http://dbpedia.org/resource/Emeryville%2C_California +
|
| http://dbpedia.org/ontology/numberOfEmployees
|
5400
|
| http://dbpedia.org/ontology/product
|
http://dbpedia.org/resource/Vaccine +
, http://dbpedia.org/resource/Blood_test +
, http://dbpedia.org/resource/Biopharmaceutical +
|
| http://dbpedia.org/ontology/revenue
|
1.921E9
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Chironlogo.png?width=300 +
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
https://web.archive.org/web/20070104082853/http:/www.chiron.com/ +
, http://www.chiron.com/ +
|
| http://dbpedia.org/ontology/wikiPageID
|
1184467
|
| http://dbpedia.org/ontology/wikiPageLength
|
22687
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1086352586
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Michael_Houghton_%28virologist%29 +
, http://dbpedia.org/resource/Qui-Lim_Choo +
, http://dbpedia.org/resource/University_of_California%2C_Berkeley +
, http://dbpedia.org/resource/Becaplermin +
, http://dbpedia.org/resource/Kidney_cancer +
, http://dbpedia.org/resource/Berlex_Laboratories +
, http://dbpedia.org/resource/Crucell +
, http://dbpedia.org/resource/Eastman_Kodak +
, http://dbpedia.org/resource/Betaseron +
, http://dbpedia.org/resource/Blood_test +
, http://dbpedia.org/resource/George_Kuo +
, http://dbpedia.org/resource/Category:Companies_based_in_Emeryville%2C_California +
, http://dbpedia.org/resource/Metastasis +
, http://dbpedia.org/resource/Tobramycin +
, http://dbpedia.org/resource/University_of_California +
, http://dbpedia.org/resource/Medicines_and_Healthcare_products_Regulatory_Agency +
, http://dbpedia.org/resource/Delaware +
, http://dbpedia.org/resource/Multinational_corporation +
, http://dbpedia.org/resource/Melanoma +
, http://dbpedia.org/resource/Johnson_&_Johnson +
, http://dbpedia.org/resource/Influenza_vaccine +
, http://dbpedia.org/resource/Cloning +
, http://dbpedia.org/resource/Category:Vaccine_producers +
, http://dbpedia.org/resource/Ortho-McNeil_Pharmaceutical +
, http://dbpedia.org/resource/Bayer_AG +
, http://dbpedia.org/resource/Daniel_Andreas_San_Diego +
, http://dbpedia.org/resource/Proleukin +
, http://dbpedia.org/resource/University_of_California%2C_San_Francisco +
, http://dbpedia.org/resource/Class_action +
, http://dbpedia.org/resource/Category:1981_establishments_in_California +
, http://dbpedia.org/resource/Revolutionary_Cells_-_Animal_Liberation_Brigade +
, http://dbpedia.org/resource/Food_and_Drug_Administration_%28United_States%29 +
, http://dbpedia.org/resource/Grifols +
, http://dbpedia.org/resource/Hepatitis_C +
, http://dbpedia.org/resource/British_Medical_Association +
, http://dbpedia.org/resource/William_J._Rutter +
, http://dbpedia.org/resource/FBI_Most_Wanted_Terrorists +
, http://dbpedia.org/resource/Huntingdon_Life_Sciences +
, http://dbpedia.org/resource/Pablo_DT_Valenzuela +
, http://dbpedia.org/resource/Antibiotic +
, http://dbpedia.org/resource/Category:2006_mergers_and_acquisitions +
, http://dbpedia.org/resource/Cystic_fibrosis +
, http://dbpedia.org/resource/Pentavalent_vaccine +
, http://dbpedia.org/resource/Emeryville%2C_California +
, http://dbpedia.org/resource/Diabetes_mellitus +
, http://dbpedia.org/resource/Vaccine +
, http://dbpedia.org/resource/Category:Companies_disestablished_in_2006 +
, http://dbpedia.org/resource/Quinvaxem +
, http://dbpedia.org/resource/Multiple_sclerosis +
, http://dbpedia.org/resource/GlaxoSmithKline +
, http://dbpedia.org/resource/Category:Companies_established_in_1981 +
, http://dbpedia.org/resource/Category:2006_disestablishments_in_California +
, http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/Food_and_Drug_Administration +
, http://dbpedia.org/resource/Nucleic_acid_test +
, http://dbpedia.org/resource/MMR_vaccine +
, http://dbpedia.org/resource/File:Chironlogo.png +
, http://dbpedia.org/resource/Warner-Lambert_Company +
, http://dbpedia.org/resource/Liverpool +
, http://dbpedia.org/resource/Hepatitis_C_virus +
, http://dbpedia.org/resource/Patent_infringement +
, http://dbpedia.org/resource/Regranex +
, http://dbpedia.org/resource/Fluvirin +
, http://dbpedia.org/resource/Biopharmaceutical +
, http://dbpedia.org/resource/Polymerase +
, http://dbpedia.org/resource/DuPont +
, http://dbpedia.org/resource/Novartis +
, http://dbpedia.org/resource/Daniel_W._Bradley +
|
| http://dbpedia.org/property/defunct
|
"2006-04-20"^^xsd:date
|
| http://dbpedia.org/property/fate
|
In 2014, its assets related to blood testing and vaccines subsequently sold to Grifols and GlaxoSmithKline, respectively.
, Acquired by Novartis in 2006.
|
| http://dbpedia.org/property/foundation
|
1981
|
| http://dbpedia.org/property/homepage
|
http://www.chiron.com/ +
|
| http://dbpedia.org/property/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/property/location
|
Emeryville, California, USA
|
| http://dbpedia.org/property/logo
|
http://dbpedia.org/resource/File:Chironlogo.png +
|
| http://dbpedia.org/property/name
|
Chiron Corporation
|
| http://dbpedia.org/property/numEmployees
|
5400
|
| http://dbpedia.org/property/products
|
vaccines,
, Biopharmaceuticals,
, blood testing
|
| http://dbpedia.org/property/revenue
|
1.921E9
|
| http://dbpedia.org/property/type
|
Subsidiary
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Authority_control +
, http://dbpedia.org/resource/Template:Respell +
, http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:Use_mdy_dates +
, http://dbpedia.org/resource/Template:Emeryville%2C_California +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:End_date_and_age +
, http://dbpedia.org/resource/Template:IPAc-en +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Profit +
|
| http://dbpedia.org/property/wordnet type
|
http://www.w3.org/2006/03/wn/wn20/instances/synset-company-noun-1 +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:2006_disestablishments_in_California +
, http://dbpedia.org/resource/Category:Companies_based_in_Emeryville%2C_California +
, http://dbpedia.org/resource/Category:Vaccine_producers +
, http://dbpedia.org/resource/Category:1981_establishments_in_California +
, http://dbpedia.org/resource/Category:Companies_disestablished_in_2006 +
, http://dbpedia.org/resource/Category:Companies_established_in_1981 +
, http://dbpedia.org/resource/Category:2006_mergers_and_acquisitions +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Firm +
|
| http://www.w3.org/2004/02/skos/core#closeMatch
|
http://www.grid.ac/institutes/grid.418424.f +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Chiron_Corporation?oldid=1086352586&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Chironlogo.png +
|
| http://xmlns.com/foaf/0.1/homepage
|
http://www.chiron.com/ +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Chiron_Corporation +
|
| http://xmlns.com/foaf/0.1/name
|
Chiron Corporation
|
| owl:sameAs |
http://dbpedia.org/resource/Chiron_Corporation +
, http://www4.wiwiss.fu-berlin.de/wikicompany/resource/Chiron_Corporation +
, http://rdf.freebase.com/ns/m.04fch1 +
, http://yago-knowledge.org/resource/Chiron_Corporation +
, http://sw.cyc.com/concept/Mx4rwFIR1ZwpEbGdrcN5Y29ycA +
, https://global.dbpedia.org/id/9YU8 +
, http://de.dbpedia.org/resource/Chiron_Corporation +
, http://www.wikidata.org/entity/Q1074758 +
, http://vi.dbpedia.org/resource/Chiron_Corporation +
|
| rdf:type |
http://dbpedia.org/class/yago/Organization108008335 +
, http://umbel.org/umbel/rc/Organization +
, http://dbpedia.org/class/yago/WikicatCompaniesDisestablishedIn2006 +
, http://dbpedia.org/class/yago/YagoLegalActorGeo +
, http://dbpedia.org/class/yago/YagoLegalActor +
, http://dbpedia.org/class/yago/WikicatCompaniesEstablishedIn1981 +
, http://dbpedia.org/ontology/Agent +
, http://www.wikidata.org/entity/Q24229398 +
, http://dbpedia.org/class/yago/SocialGroup107950920 +
, http://www.wikidata.org/entity/Q4830453 +
, http://www.wikidata.org/entity/Q43229 +
, http://umbel.org/umbel/rc/Business +
, http://dbpedia.org/class/yago/Institution108053576 +
, http://dbpedia.org/ontology/Organisation +
, http://dbpedia.org/class/yago/WikicatBiotechnologyCompaniesOfTheUnitedStates +
, http://dbpedia.org/class/yago/YagoPermanentlyLocatedEntity +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://schema.org/Organization +
, http://dbpedia.org/class/yago/Company108058098 +
, http://dbpedia.org/class/yago/WikicatBiotechnologyCompanies +
, http://dbpedia.org/ontology/Company +
, http://dbpedia.org/class/yago/WikicatDefunctCompaniesOfTheUnitedStates +
, http://dbpedia.org/class/yago/WikicatCompaniesBasedInEmeryville%2CCalifornia +
, http://dbpedia.org/class/yago/Group100031264 +
, http://dbpedia.org/class/yago/Abstraction100002137 +
|
| rdfs:comment |
Die Chiron Corporation war ein internation … Die Chiron Corporation war ein international aufgestelltes US-amerikanisches Biotechnologieunternehmen mit Sitz in Emeryville in Kalifornien, das am 20. April 2006 von Novartis übernommen wurde. Die Chiron Corporation wurde 1981 durch William Rutter, und gegründet und 1983 an die Börse gebracht. Den ersten Gewinn konnte das Unternehmen 1990 vorweisen. Im Jahr 1991 wurde die für 660 Millionen US-Dollar übernommen. Dies stellte die bis dahin größte Akquisition eines Biotechnologieunternehmens dar. Die Cetus Corp. hatte Aldesleukin (Interleukin-2, Proleukin®) entwickelt, das 1992 von der Food and Drug Administration (FDA) die Marktzulassung für die Behandlung von metastasierendem Nierenkrebs, und 1998 zur Behandlung des metastasierenden Melanoms bekam. Chiron erwarb 1995 die Iolab-Divisionkam. Chiron erwarb 1995 die Iolab-Division
, Chiron Corporation (/ˈkaɪrɒn/ KY-ron) was … Chiron Corporation (/ˈkaɪrɒn/ KY-ron) was an American multinational biotechnology firm founded in 1981, based in Emeryville, California, that was acquired by Novartis on April 20, 2006. It had offices and facilities in eighteen countries on five continents. Chiron's business and research was in three main areas: biopharmaceuticals, vaccines, and blood testing. Chiron's vaccines and blood testing units were combined to form Novartis Vaccines and Diagnostics, while Chiron BioPharmaceuticals was integrated into Novartis Pharmaceuticals. In 2014, Novartis completed the sale of its blood transfusion diagnostics unit to Grifols and announced agreements for the sale of its vaccines unit to GlaxoSmithKline.e of its vaccines unit to GlaxoSmithKline.
|
| rdfs:label |
Chiron Corporation
|
